Does DEFERASIROX Cause Product solubility abnormal? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Product solubility abnormal have been filed in association with DEFERASIROX (Deferasirox). This represents 0.1% of all adverse event reports for DEFERASIROX.
8
Reports of Product solubility abnormal with DEFERASIROX
0.1%
of all DEFERASIROX reports
0
Deaths
2
Hospitalizations
How Dangerous Is Product solubility abnormal From DEFERASIROX?
Of the 8 reports, 2 (25.0%) required hospitalization.
Is Product solubility abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEFERASIROX. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does DEFERASIROX Cause?
Death (1,583)
Diarrhoea (993)
Serum ferritin increased (732)
Haemoglobin decreased (615)
Pyrexia (607)
Malaise (605)
Nausea (603)
Sickle cell anaemia with crisis (570)
Vomiting (520)
Pneumonia (494)
What Other Drugs Cause Product solubility abnormal?
BUPRENORPHINE (498)
BUPRENORPHINE\NALOXONE (274)
POLYETHYLENE GLYCOL 3350 (220)
CHOLESTYRAMINE (193)
PATIROMER (107)
LEVOTHYROXINE (100)
SOMATROPIN (98)
EXENATIDE (97)
ESTRADIOL (94)
NITROGLYCERIN (81)
Which DEFERASIROX Alternatives Have Lower Product solubility abnormal Risk?
DEFERASIROX vs DEFERIPRONE
DEFERASIROX vs DEFEROXAMINE
DEFERASIROX vs DEFIBROTIDE
DEFERASIROX vs DEFLAZACORT
DEFERASIROX vs DEGARELIX